Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pfizer (NY:PFE)

23.87 -0.99 (-3.98%)
Official Closing Price Updated: 7:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Market Monitor News August 06 BMO - Wall Street Slides as Services Sector Falters, but Palantir Rockets Past Expectations
A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red. 
Via Chartmill
Topics Economy
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca
Via Stocktwits
Why Shares of Pfizer Soared Today
The large pharmaceutical company reported strong second-quarter earnings results. 
Via The Motley Fool
Topics Government World Trade
Will Amgen, Already Above Its 50-Day Line, Break Out On This Earnings News?
Amgen crushed second-quarter forecasts late Tuesday. The news could push Amgen stock into a breakout. 
Via Investor's Business Daily
Top S&P500 movers in Tuesday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Pfizer In Talks With Trump Administration Regarding Lower Drug Prices And Tariffs, Says CEO: Stock Rallies On Improved Full-Year Guidance, Upbeat Q2 Report
Via Stocktwits
Topics Government
Looking for the most active stocks in the S&P500 index on Tuesday?
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest... 
Via Chartmill
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today
Via Stocktwits
TSMC Stock Slips On Suspected Trade Secrets Theft
TSMC stock fall on news of suspected trade secrets theft at the semiconductor manufacturing powerhouse, a major player in the AI chip market. 
Via Investor's Business Daily
Topics Artificial Intelligence
Which S&P500 stocks are moving on Tuesday?
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday?
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. 
Via Benzinga
Topics Economy Government
What's going on in today's session: S&P500 gap up and gap down stocks
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Pfizer Beats Expectations In Q2 2025, Raises EPS Guidance
Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78. 
Via Talk Markets
Pfizer Cost-Cut Initiatives More Than Offset Tariffs Impact, Raises Outlook
Pfizer posts better-than-expected Q2 earnings and sales, raises 2025 EPS outlook, and outlines $7.7 billion in cost-saving initiatives through 2027. 
Via Benzinga
Dow Surges Over 100 Points; Pfizer Earnings Top Views
 
Via Benzinga
Topics Stocks
Pfizer Smashes Earnings Forecasts And Raises Outlook; Shares Jump
Shares advanced within striking distance of their 50-day line. 
Via Investor's Business Daily
Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue... 
Via StockStory
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
It's been a roller-coaster ride for Pfizer's stock over the past half-decade. 
Via The Motley Fool
Topics Intellectual Property
Pfizer (NYSE:PFE) Reports Upbeat Q2
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q2 CY2025, with sales up 10.3% year on year to $14.65 billion. The company expects the full year’s revenue to... 
Via StockStory
Dow Futures Rise As Investors Shift Focus To Earnings: PFE, PLTR, TSLA, BP, AMD Among Stocks To Watch
Via Stocktwits
Topics Stocks
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
From Pfizer Inc.
Via Business Wire
Stock Market Today: US Stock Futures Inch Higher, As Analysts Warn of Volatile August—AMD, Pfizer, Caterpillar In Focus
U.S. stock futures are inching higher on Tuesday, following a strong rally on Monday, with major benchmark indices in the green. 
Via Benzinga
3 Healthcare Stocks Paying the Highest Dividends of 2025
Income investors seeking juicy dividends should check out these healthcare stocks. 
Via The Motley Fool
Topics Intellectual Property
3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 6.72% -- That Make for No-Brainer Buys in August
Three time-tested companies with rock-solid payouts can pad investors' pocketbooks for a long time to come. 
Via The Motley Fool
Topics Energy Government World Trade
S&P 500 Snaps Four-Day Losing Streak: Investor Sentiment Improves, Fear Index In 'Greed' Zone
At a current reading of 56.5, the index remained in the "Greed" zone on Monday, versus a prior reading of 56.1. 
Via Benzinga
Topics Stocks
Caterpillar, Pfizer And 3 Stocks To Watch Heading Into Tuesday
US stock futures up, key stocks to watch: Caterpillar, Pfizer, Paymentus, Palantir, AMD. Check out premarket coverage. 
Via Benzinga
The Smartest Dividend Stocks to Buy With $10,000 Right Now
Thanks to some misguided short-term setbacks, investors can scoop up a trio of dividend-paying bargains here. 
Via The Motley Fool
Topics Earnings World Trade
Michael McTague: How can anyone afford breakthrough medicines?
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national spending on personal health care has 
Via Equities.com
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.